Leyden Labs

Leyden Labs is developing an innovative nasal spray that offers protection against flu and other respiratory viruses. Invest-NL is investing € 15 million in Leyden Labs, together with the European Innovation Council (EIC) Fund, which is also contributing € 15 million. With this investment, the company can accelerate its clinical programme and better prepare Europe for future pandemics. 

This investment aligns well with our impact objectives to improve the accessibility and affordability of healthcare, both by protecting vulnerable groups and focusing on prevention.